Delivery Order SPE2DB22D6029-SPE2DB24FU1DR
Award Date
6/3/24
Potential Completion Date
6/25/24
Potential Value
$39K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The $12,345.34 contract is for the provision of VYNDAMAX 61 MG CAPSULE UD 30S, a specialty pharmaceutical product, with a period of performance through April 9, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) valued at up to...
The U.S. Department of Defense's Medical Supply Chain (DLA Troop Support Medical) awarded a delivery order contract valued at $12,960.30 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the Defense Logistics Agency, valued at up to $999,999,999.00 through December 31, 2025. The IDC enables...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $12,345.34 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The order is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a specialty pharmaceutical product, with a completion date of March 4, 2024. This award is issued under Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued up to...
The U.S. Defense Logistics Agency (DLA) awarded a $12,960.30 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of VYNDAMAX 61 MG CAPSULE UD 30S. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that runs through December 31, 2025, which serves as the primary contract vehicle for AmerisourceBergen to provide pharmaceutical products and medical...
The U.S. Department of Defense, Medical Supply Chain awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution services company. The contract, valued at $49,381.36, is for the provision of VYNDAMAX 61 MG CAPSULE UD 30S, a specialty pharmaceutical product. This delivery order is likely part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $24,690.70 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $12,960.30 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VYNDAMAX 61 MG CAPSULE UD 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $12,960.30, is a Firm Fixed Price Delivery Order that runs through July 30, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office Division. The $12,960.30 Firm Fixed Price Delivery Order is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with a period of performance ending on September 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S. The $13,408.24 firm fixed-price contract has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...